litlas
Log inCreate account

Michael W. Parker

Active 1988–2025

156
Papers
19,724
Citations
89
h-index
150
i10-index

Citations

Citations per year for Michael W. Parker1967: 1 citations1974: 1 citations1989: 4 citations1990: 15 citations1991: 22 citations1992: 22 citations1993: 30 citations1994: 54 citations1995: 50 citations1996: 59 citations1997: 90 citations1998: 106 citations1999: 75 citations2000: 67 citations2001: 140 citations2002: 129 citations2003: 102 citations2004: 144 citations2005: 176 citations2006: 140 citations2007: 175 citations2008: 151 citations2009: 156 citations2010: 187 citations2011: 176 citations2012: 187 citations2013: 127 citations2014: 180 citations2015: 195 citations2016: 152 citations2017: 153 citations2018: 142 citations2019: 446 citations2020: 517 citations2021: 482 citations2022: 419 citations2023: 337 citations2024: 539 citations2025: 274 citations2026: 11 citations1968–1973: no citations, so these years are not shown1975–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,912 citing papers, 25.1% of this breakdownChina: 759 citing papers, 9.9% of this breakdownUnited Kingdom: 660 citing papers, 8.6% of this breakdownAustralia: 609 citing papers, 8% of this breakdownGermany: 463 citing papers, 6.1% of this breakdownFrance: 314 citing papers, 4.1% of this breakdownItaly: 261 citing papers, 3.4% of this breakdownCanada: 235 citing papers, 3.1% of this breakdownSwitzerland: 197 citing papers, 2.6% of this breakdownJapan: 175 citing papers, 2.3% of this breakdownIndia: 173 citing papers, 2.3% of this breakdownSpain: 138 citing papers, 1.8% of this breakdown
0%25.1%Other 22.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology40%
  • Medicine35.2%
  • Immunology and Microbiology9.3%
  • Neuroscience3.1%
  • Computer Science2.1%
  • Agricultural and Biological Sciences2%
  • Other8.3%

Topics

  • Alzheimer's disease research and treatments2.6%
  • Glutathione Transferases and Polymorphisms1.9%
  • Computational Drug Discovery Methods1.9%
  • Metabolism, Diabetes, and Cancer1.8%
  • Genomics, phytochemicals, and oxidative stress1.5%
  • Streptococcal Infections and Treatments1.4%
  • Other88.9%

Coauthors

All papers

Open in search
  1. Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia

    Authors: Marisa R. Morrow, Battsetseg Batchuluun, Jianhan Wu, Elham Ahmadi, Julie M. Leroux, Pedrum Mohammadi‐Shemirani, Eric M. Desjardins, Zhichao Wang, Evangelia E. Tsakiridis, Declan C.T. Lavoie, Amir Reihani, Brennan K. Smith, Jacek M. Kwiecień, James Lally, Tracy L. Nero, Michael W. Parker, Kjetil Ask, John W. Scott, Lei Jiang, Guillaume Paré, Stephen L. Pinkosky, Gregory R. Steinberg - Cell Metabolism 2022 cited by 180

  2. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth

    Authors: Jonathan B. Baell, David J. Leaver, S.J. Hermans, Gemma L. Kelly, Margs S. Brennan, Natalie L. Downer, Nghi Nguyen, Johannes Wichmann, Helen M. McRae, Yuqing Yang, Ben Cleary, H. Rachel Lagiakos, Stephen Mieruszynski, Guido Pacini, Hannah Vanyai, Maria Bergamasco, Rose E. May, Bethany K. Davey, Kimberly J Morgan, A.J. Sealey, Beinan Wang, Natasha Zamudio, Stephen Wilcox, Alexandra L. Garnham, Bilal N. Sheikh, Brandon J. Aubrey, Karen Doggett, Matthew Chung, Melanie de Silva, John D. Bentley, Pat Pilling, Meghan Hattarki, Olan Dolezal, Matthew L. Dennis, Hendrik Falk, Bin Ren, Susan A. Charman, Karen L. White, Jai Rautela, Andrea Newbold, Edwin D. Hawkins, Ricky W. Johnstone, Nicholas D. Huntington, Thomas S. Peat, Joan K. Heath, Andreas Strasser, Michael W. Parker, Gordon K. Smyth, Ian P. Street, Brendon J. Monahan, Anne K. Voss, Tim Thomas - Nature 2018 cited by 314

  3. Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK β1 isoforms

    Authors: Stephen L. Pinkosky, John W. Scott, Eric M. Desjardins, Brennan K. Smith, Emily A. Day, Rebecca J. Ford, Christopher G. Langendorf, Naomi X.Y. Ling, Tracy L. Nero, Kim Loh, Sandra Galić, Ashfaqul Hoque, William J. Smiles, Kevin R. W. Ngoei, Michael W. Parker, Yan Yan, Karsten Melcher, Bruce E. Kemp, Jonathan S. Oakhill, Gregory R. Steinberg - Nature Metabolism 2020 cited by 135

  4. Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

    Authors: C. Glenn Begley, Mark Ashton, Jonathan B. Baell, Michael D. Bettess, Michael P. Brown, Brett Carter, William N. Charman, Christopher Davis, Simon Fisher, Ian H. Frazer, Gautam Anand, Michael P. Jennings, Philip E. Kearney, Eloise C. Keeffe, Darren J. Kelly, Angel F. López, Michael A. McGuckin, Michael W. Parker, Craig R. Rayner, Brett J. Roberts, James S. Rush, Mark Sullivan - Science Translational Medicine 2021 cited by 151

  5. Oncogenic protein interfaces: small molecules, big challenges

    Authors: Tracy L. Nero, Craig J. Morton, Jessica K. Holien, J. Wielens, Michael W. Parker - Nature reviews. Cancer 2014 cited by 305

  6. Repurposing of drugs as STAT3 inhibitors for cancer therapy

    Authors: Pathum Thilakasiri, Rhynelle S. Dmello, Tracy L. Nero, Michael W. Parker, Matthias Ernst, Ashwini L. Chand - Seminars in Cancer Biology 2019 cited by 110

  7. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites

    Authors: David Braig, Tracy L. Nero, Hans-Georg Koch, Benedict Kaiser, Xiaowei Wang, Jan Thiele, Craig J. Morton, Johannes Zeller, Jurij Kiefer, Lawrence A. Potempa, Natalie A. Mellett, Luke A. Miles, Xiao-Jun Du, Peter J. Meikle, Markus Huber‐Lang, G. Björn Stark, Michael W. Parker, Karlheinz Peter, Steffen U. Eisenhardt - Nature Communications 2017 cited by 209

  8. An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability

    Authors: Zsuzsanna Nagy, Janith A. Seneviratne, Maxwell Kanikevich, William K. Chang, Chelsea Mayoh, Pooja Venkat, Yanhua Du, Cizhong Jiang, Alice Salib, Jessica Koach, Daniel R. Carter, Rituparna Mittra, Tao Liu, Michael W. Parker, Belamy B. Cheung, Glenn M. Marshall - Nature Communications 2021 cited by 88

  9. Structure of native HIV-1 cores and their interactions with IP6 and CypA

    Authors: Tao Ni, Yanan Zhu, Zhengyi Yang, Chaoyi Xu, Yuriy Chaban, Tanya Nesterova, Jiying Ning, Till Böcking, Michael W. Parker, Christina Monnie, Jin-Woo Ahn, Juan R. Perilla, Peijun Zhang - Science Advances 2021 cited by 72

  10. A novel phosphocholine‐mimetic inhibits a pro‐inflammatory conformational change in C‐reactive protein

    Authors: Johannes Zeller, Karen S. Cheung Tung Shing, Tracy L. Nero, James D. McFadyen, Guy Y. Krippner, Balázs Bogner, Sheena Kreuzaler, Jurij Kiefer, Verena K. Horner, David Braig, Habiba Danish, Sara Baratchi, Mark Fricke, Xiaowei Wang, Michel Kather, Bernd Kammerer, Kevin Woollard, Prerna Sharma, Craig J. Morton, Geoffrey A. Pietersz, Michael W. Parker, Karlheinz Peter, Steffen U. Eisenhardt - EMBO Molecular Medicine 2022 cited by 49

  11. C-reactive protein, immunothrombosis and venous thromboembolism

    Authors: Caroline Dix, Johannes Zeller, Hannah Stevens, Steffen U. Eisenhardt, Karen S. Cheung Tung Shing, Tracy L. Nero, Craig J. Morton, Michael W. Parker, Karlheinz Peter, James D. McFadyen - Frontiers in Immunology 2022 cited by 88

  12. Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers

    Authors: Thomas S. Fulford, Caroline Soliman, Rebecca G. Castle, Marc Rigau, Zheng Ruan, Olan Dolezal, Rebecca Seneviratna, Hamish G. Brown, Eric Hanssen, Andrew Hammet, Shihan Li, Samuel J. Redmond, Amy W. Chung, Michael A. Gorman, Michael W. Parker, Onisha Patel, Thomas S. Peat, Janet Newman, Andreas Behren, Nicholas A. Gherardin, Dale I. Godfrey, Adam P. Uldrich - Nature Immunology 2024 cited by 44

  13. Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor

    Authors: Andrew J. Brooks, Wei Dai, Megan L. O’Mara, Daniel Abankwa, Yash Chhabra, Rebecca Pelekanos, Olivier Gardon, Kathryn A. Tunny, Kristopher M. Blucher, Craig J. Morton, Michael W. Parker, Emma Sierecki, Yann Gambin, Guillermo A. Gómez, Kirill Alexandrov, Ian A. Wilson, Manolis Doxastakis, Alan E. Mark, Michael J. Waters - Science 2014 cited by 415

  14. Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis

    Authors: Luke A. Miles, S.J. Hermans, Gabriela A. N. Crespi, Jonathan H. Gooi, Larissa Doughty, Tracy L. Nero, Jasmina Markulić, Andreas Ebneth, Berthold Wroblowski, Daniel Oehlrich, Andrés A. Trabanco, M. Rives, Inès Royaux, Nancy C. Hancock, Michael W. Parker - iScience 2019 cited by 83

  15. The Fingerprinting Algorithm for Digital Image and Video

    Authors: Sophie E. Broughton, Urmi Dhagat, Timothy R. Hercus, Tracy L. Nero, Michele A. Grimbaldeston, Claudine S. Bonder, Angel F. López, Michael W. Parker - Immunological Reviews 2003 cited by 239

  16. Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis

    Authors: Chantal L. Márquez, Derrick Lau, James Walsh, Vaibhav Shah, Conall McGuinness, Andrew Kam Ho Wong, Anupriya Aggarwal, Michael W. Parker, David A. Jacques, Stuart Turville, Till Böcking - eLife 2018 cited by 119

  17. Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies

    Authors: Gabriela A. N. Crespi, S.J. Hermans, Michael W. Parker, Luke A. Miles - Scientific Reports 2015 cited by 96

  18. Role of nicotinic acetylcholine receptor subunits in the mode of action of neonicotinoid, sulfoximine and spinosyn insecticides in Drosophila melanogaster

    Authors: Trent Perry, Wei Chen, Razi Ghazali, Ying Ting Yang, Danielle Christesen, Felipe Martelli, Chris Lumb, Ngoc Bao Hang Luong, Judith Mitchell, Jessica K. Holien, Michael W. Parker, Thomas C. Sparks, Philip Batterham - Insect Biochemistry and Molecular Biology 2021 cited by 81

  19. Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy

    Authors: Stanley C. Xie, Riley D. Metcalfe, Elyse Dunn, Craig J. Morton, Shih‐Chung Huang, Tanya Puhalovich, Yawei Du, Sergio Wittlin, Shuai Nie, Madeline R. Luth, Li‐Ting Ma, Misook Kim, Charisse Flerida A. Pasaje, Krittikorn Kümpornsin, Carlo Giannangelo, Fiona J. Houghton, Alisje Churchyard, Mufuliat T. Famodimu, Daniel C. Barry, David L. Gillett, Sumanta Dey, Clara C. Kosasih, W. Newman, Jacquin C. Niles, Lee M, Jake Baum, Sabine Ottilie, Elizabeth A. Winzeler, Darren J. Creek, Nicholas A. Williamson, Michael W. Parker, Stephen Brand, Steven Langston, Lawrence R. Dick, Michael D. W. Griffin, Alexandra E. Gould, Leann Tilley - Science 2022 cited by 56

  20. Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure

    Authors: K. Faysal, James Walsh, Nadine Renner, Chantal L. Márquez, Vaibhav B. Shah, Andrew Tuckwell, Michelle P. Christie, Michael W. Parker, Stuart Turville, Greg J. Towers, Leo C. James, David A. Jacques, Till Böcking - eLife 2024 cited by 45

  21. A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development

    Authors: Martina Sanderson‐Smith, David M. P. De Oliveira, Julien Guglielmini, David J. McMillan, Therese Vu, Jessica K. Holien, Anna Henningham, Andrew C. Steer, Debra E. Bessen, James B. Dale, Nigel Curtis, Bernard Beall, Mark J. Walker, Michael W. Parker, Jonathan R. Carapetis, Laurence Van Melderen, Kadaba S. Sriprakash, Pierre R. Smeesters - The Journal of Infectious Diseases 2014 cited by 317

  22. TRIM16 Acts as an E3 Ubiquitin Ligase and Can Heterodimerize with Other TRIM Family Members

    Authors: Jessica L. Bell, Alena Malyukova, Jessica K. Holien, Jessica Koach, Michael W. Parker, Maria Kavallaris, Glenn M. Marshall, Belamy B. Cheung - PLoS ONE 2012 cited by 116

  23. Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: Therapeutic implications for cardiovascular diseases

    Authors: Johannes Zeller, Balázs Bogner, James D. McFadyen, Jurij Kiefer, David Braig, Geoffrey A. Pietersz, Guy Y. Krippner, Tracy L. Nero, Craig J. Morton, Karen S. Cheung Tung Shing, Michael W. Parker, Karlheinz Peter, Steffen U. Eisenhardt - Pharmacology & Therapeutics 2022 cited by 59

  24. Covalent Inhibition by a Natural Product-Inspired Latent Electrophile

    Authors: David P. Byun, Jennifer M. Ritchie, Ye‐Jin Jung, Ronald J. Holewinski, Hong‐Rae Kim, Ravichandra Tagirasa, Joseph Ivanic, Claire M. Weekley, Michael W. Parker, Þorkell Andrésson, Euna Yoo - Journal of the American Chemical Society 2023 cited by 29